Genetically modifications like using silencing RNA of the mutant SOD1 or TARDBP, ALS2, and ALS4 genes, in familial ALS patients could be considered as a good optional therapeutic method (71). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.